United States Securities and Exchange Commission · EDGAR Accession 0001669191-25-000512

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 2087846
Raising via NetCapital Funding Portal Inc.

Vertical Longevity Pharmaceuticals, Inc.

CorporationDEIncorporated 2025Irvine, CAvertical-longevity-pharma.com
A

The Offering

as disclosed in this filing
Common Stock
$0.97
$10,001
$500,000
January 16, 2026
Expired 149 days ago
$0max $500,000

Target is 2% of the maximum. Over-subscriptions accepted, allocated first-come, first-served basis.

B

Financial Condition

two fiscal years, as filed
Pre-revenue2 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income00
Total assets00
Cash & equivalents00
Accounts receivable00
Short-term debt00
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.